Related Experiment Video
Updated: May 29, 2026
07:25
Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Nature
|September 13, 2011
Summary
This genome-wide association study identified 16 new genetic regions influencing blood pressure. A genetic risk score linked these variants to hypertension and cardiovascular diseases.
Area of Science:
- Genetics
- Cardiovascular Physiology
- Public Health
Background:
- Hypertension affects over one billion people globally.
- Elevated blood pressure increases cardiovascular event risk.
- Blood pressure is a heritable trait influenced by genetics and environment.
Purpose of the Study:
- To identify novel genetic loci associated with blood pressure.
- To investigate the genetic risk score's association with hypertension and related conditions.
- To explore blood pressure genetics across diverse ancestries.
Main Methods:
- Multi-stage genome-wide association study (GWAS) in 200,000 European individuals.
- Analysis of systolic and diastolic blood pressure.
- Development and validation of a genetic risk score using 29 variants.
Main Results:
- Identified 16 novel genetic loci influencing blood pressure.
- Six loci contained known blood pressure regulatory genes; ten provided new insights.
- Genetic risk score associated with hypertension, left ventricular wall thickness, stroke, and coronary artery disease.
- Observed cross-ancestry associations with blood pressure.
Conclusions:
- New insights into blood pressure genetics and physiology.
- Potential for novel therapeutic targets for cardiovascular disease prevention.
- Genetic risk score is a significant predictor of hypertension and cardiovascular outcomes.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Factors affecting Blood pressure
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...